Author/Creator: Lollar, P. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Lollar, P.

1. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor. (9th August 2017)

Authors:: Deng, W.; Wang, Y.; Druzak, S. A.; Healey, J. F.; Syed, A. K.; Lollar, P.; Li, R.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 15:Number 9(2017)
Page Start:: 1867
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Anti‐C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model. (13th August 2018)

Authors:: Batsuli, G.; Ito, J.; Mercer, R.; Baldwin, W. H.; Cox, C.; Parker, E. T.; Healey, J. F.; Lollar, P.; Meeks, S. L.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 16:Number 9(2018)
Page Start:: 1779
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Anti‐factor VIII antibodies in brothers with haemophilia A share similar characteristics. Issue 2 (8th November 2016)

Authors:: Kahle, J.; Orlowski, A.; Stichel, D.; Healey, J. F.; Parker, E. T.; Donfield, S. M.; Astermark, J.; Berntorp, E.; Lollar, P.; Schwabe, D.; Königs, C.
Journal:: Haemophilia
Issue:: Volume 23:Issue 2(2017)
Page Start:: 292
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene. (8th January 2016)

Authors:: Chao, B. N.; Baldwin, W. H.; Healey, J. F.; Parker, E. T.; Shafer‐Weaver, K.; Cox, C.; Jiang, P.; Kanellopoulou, C.; Lollar, P.; Meeks, S. L.; Lenardo, M. J.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 14:Number 2(2016:Feb.)
Page Start:: 346
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Delimiting the autoinhibitory module of von Willebrand factor. (16th August 2018)

Authors:: Deng, W.; Voos, K. M.; Colucci, J. K.; Legan, E. R.; Ortlund, E. A.; Lollar, P.; Li, R.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 16:Number 10(2018)
Page Start:: 2097
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation. (11th January 2018)

Authors:: Healey, J. F.; Parker, E. T.; Lollar, P.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 16:Number 2(2018)
Page Start:: 303
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Lack of recombinant factor VIII B‐domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII. (21st April 2014)

Authors:: Grushin, K.; Miller, J.; Dalm, D.; Parker, E. T.; Healey, J. F.; Lollar, P.; Stoilova‐McPhie, S.
Journal:: Haemophilia
Issue:: Volume 20:Number 5(2014:Sep.)
Page Start:: 723
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Lack of recombinant factor VIII B‐domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII. (21st April 2014)

Authors:: Grushin, K.; Miller, J.; Dalm, D.; Parker, E. T.; Healey, J. F.; Lollar, P.; Stoilova‐McPhie, S.
Journal:: Haemophilia
Issue:: Volume 20(2014)Supplement 5
Page Start:: 723
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Philip J. Fay (1953–2014). (3rd September 2014)

Authors:: Krishnaswamy, S.; Lollar, P.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 12:Number 9(2014:Sep.)
Page Start:: 1576
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Porcine recombinant factor VIII (Obizur; OBI‐1; BAX801): product characteristics and preclinical profile. (17th August 2015)

Authors:: Lillicrap, D.; Schiviz, A.; Apostol, C.; Wojciechowski, P.; Horling, F.; Lai, C. K.; Piskernik, C.; Hoellriegl, W.; Lollar, P.
Journal:: Haemophilia
Issue:: Volume 22:Number 2(2016:Mar.)
Page Start:: 308
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗